CRISPR Therapeutics AGCRSPNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-10.5%/yr
vs +20.7%/yr prior
5Y CAGR
-3.0%/yr
Recent deceleration
Acceleration
-31.2pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $73.54M | +0.8% |
| 2024 | $72.98M | -4.2% |
| 2023 | $76.16M | -25.7% |
| 2022 | $102.46M | +2.8% |
| 2021 | $99.69M | +16.3% |
| 2020 | $85.75M | +35.1% |
| 2019 | $63.49M | +31.5% |
| 2018 | $48.29M | +34.7% |
| 2017 | $35.84M | +15.4% |
| 2016 | $31.06M | - |